StonvexLoading…
StonvexStonvexStonvexCore line items from RHP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $664.57M | $2.58B | $1.84B | $1.25B |
Operating Income | $137.80M | $487.01M | $344.16M | $255.55M |
Net Income | $70.47M | $243.43M | $169.60M | $134.71M |
EPS (Diluted) | $1.03 | $3.77 | $2.65 | $2.13 |
Total Assets | $6.19B | $6.18B | $6.20B | $6.11B |
Total Liabilities | $4.99B | $4.97B | $4.99B | $4.87B |
Cash & Equivalents | $424.02M | $471.42M | $483.33M | $420.58M |
Free Cash Flow OCF − CapEx | $55.58M | $232.39M | $173.86M | $38.48M |
Shares Outstanding | 63.11M | 63.01M | 63.00M | 63.00M |